| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 619677 | Null | 0.00180188182321727 | 0.74212173 |
| NSC 623989 | Null | 0.00180188182321727 | 0.52928974 |
| NSC 626878 | Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride | 0.00180188182321727 | 0.67983316 |
| NSC 630602 | 1-Piperidinecarboxylic acid, 4-oxo-3,5-bis(phenyl- methylene)-, ethyl ester | 0.00180188182321727 | 0.52708305 |
| NSC 631534 | Null | 0.00180188182321727 | 0.43471793 |
| NSC 633398 | Null | 0.00180188182321727 | 0.48301377 |
| NSC 639976 | Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride | 0.00180188182321727 | 0.57127707 |
| NSC 646498 | Null | 0.00180188182321727 | 0.56342784 |
| NSC 648265 | [3-keto-Bmt(sup 1)]-[Val(sup 2)]-Cyclosporin | 0.00180188182321727 | 0.2643241 |
| NSC 656904 | ANTINEOPLASTIC-656904 | 0.00180188182321727 | 0.27078522 |